Corporate GovernanceMay 5, 2026, 04:08 PM
Inspire Medical Systems Stockholders Approve Incentive Plan & Board Declassification
AI Summary
Inspire Medical Systems, Inc. stockholders approved significant corporate governance changes at their 2026 Annual Meeting. Key approvals included an amendment and restatement of the 2018 Incentive Award Plan, authorizing an additional 2,600,000 shares for awards and implementing stricter vesting rules. Stockholders also approved an amendment to phase out the classified board structure, moving towards annual election of all directors starting in 2029. Additionally, directors were elected, the independent auditor was ratified, and executive compensation received advisory approval.
Key Highlights
- Stockholders approved the amended and restated 2018 Incentive Award Plan.
- The plan authorizes 9,903,857 shares for awards, an increase of 2,600,000 shares.
- The evergreen feature was removed, and minimum one-year vesting requirements were added.
- Stockholders approved phasing out the classified board structure for annual director elections by 2029.
- Gary L. Ellis, Georgia Melenikiotou, and Dana G. Mead, Jr. were elected as Class II directors.
- Ernst & Young LLP was ratified as the independent auditor for the year ending December 31, 2026.
- Executive officer compensation was approved on an advisory basis.
- Approximately 88% of outstanding common stock (25,287,595 shares) was represented at the meeting.
Price Impact
More from INSP